Assessing the HERV-W Env ANtagonist GNbAC1 for Evaluation in an Open Label Long-term Safety Study in Patients With Multiple Sclerosis
Clinical trial NCT03239860 · TERMINATED
Trial details
- NCT number
- NCT03239860
- Sponsor
- GeNeuro SA
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-06
- Primary completion
- 2018-11-14
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.